-
Diagnostics World | iCAD announced a collaboration with Microsoft to include a set of AI-powered mammography solutions; Revvity has launched its new IDS i20 analytical random access platform from EUROIMMUN; and more.
May 30, 2025
-
Diagnostics World | iCAD announced a collaboration with Microsoft to include a set of AI-powered mammography solutions; Revvity has launched its new IDS i20 analytical random access platform from EUROIMMUN; and more.
May 29, 2025
-
Diagnostics World | Parallel developments in wearable sensors, microfluidics, and machine learning have enabled the first-time use of a “smart bandage” in 20 human patients with chronic wounds. The latest version of the bandage, referred to as iCares, was showcased in a new study where fresh fluid from injured tissue was continually sampled to classify wound severity and healing potential.
May 28, 2025
-
Diagnostics World | Diagnostic errors remain a persistent and costly challenge in healthcare worldwide, leading to significant patient harm and financial burden. Despite advances in medical technology and research, these errors—missed, delayed, or incorrect diagnoses—cause thousands of preventable deaths and billions in healthcare costs each year.
May 23, 2025
-
Diagnostics World | Genomics has led to phenomenal scientific and medical advances over the last several decades, especially in cancer care. This progress can be seen not only in personalized therapies and drug development, but also in the ability to use biomarkers to identify the right drug for the right patient at the right time.
May 16, 2025
-
Diagnostics World | In a research project comparing the performance of 10 digital pathology tools capable of evaluating HER2 status from a common set of about 1,100 breast cancer samples, a key finding was the high level of agreement between their results and those of expert human pathologists—at least when the tumor marker was highly expressed.
May 15, 2025
-
Diagnostics World | For diagnostic labs, 2025 is a “big, complicated year” that began with a milestone “win” for laboratories when a U.S. District Court decision vacated a Food and Drug Administration (FDA) final rule that would have regulated all laboratory-developed tests (LDTs) as medical devices. Despite that win, there is no shortage of concerns and challenges facing the industry, including unknowns about the final shape of the federal reconciliation package on Capitol Hill.
May 13, 2025
-
Diagnostics World | The stethoscope, despite being more than 200 years old, is not an easily retired diagnostic device. It remains symbolic of the medical profession, even if many physicians no longer wear them and those that do are not particularly good at using them.
May 8, 2025
-
Diagnostics World | Cleveland Diagnostics announced the results of a new independent study published in Urology; Illumina and Tempus AI collaborate to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation; LinusBio announced a new partnership with the BRAIN Foundation to support advancing autism biomarker research and facilitating early identification and intervention of autism spectrum disorder; and more.
May 6, 2025
-
Diagnostics World | One of the most important tools we have to reduce mortality from cancer is early detection. Mammograms have had a significant impact in improving outcomes for patients with breast cancer, and colonoscopies have done the same for patients with colorectal cancer. But despite broad recognition of the importance of early cancer detection, our ability to screen for a wide range of cancers is quite limited. In fact, there are only five cancers for which Medicare is directed to pay for screening: breast, cervical, colon, lung, and prostate.
May 2, 2025
-
Diagnostics World | Cleveland Diagnostics announced the results of a new independent study published in Urology; Illumina and Tempus AI collaborate to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation; LinusBio announced a new partnership with the BRAIN Foundation to support advancing autism biomarker research and facilitating early identification and intervention of autism spectrum disorder; and more.
Apr 30, 2025
-
Diagnostics World | Atsena will advance their lead program, ATSN-201, for the treatment of a genetic condition that is typically diagnosed in childhood and leads to blindness later in life; Merida Biosciences plan to develop antibody-like therapeutics to help treat multiple diseases; and more.
Apr 29, 2025
-
Diagnostics World | Over the past few years, a multidisciplinary team of experts has been spreading the news that an abnormality of the heart’s left atrium (LA), known as LA myopathy, can be a marker of elevated risk of stroke and dementia—even in the absence of atrial fibrillation (AFib). The current “gap in the field” is that there is no established way to characterize the condition.
Apr 24, 2025
-
Diagnostics World | The clinical relevance and limitations of so-called “lab-in-a-box” (LIAB) diagnostics, which surged in popularity during the COVID pandemic, have since that time been under considerable scrutiny, most notably among investors still spooked by the notorious Theranos scandal. One of the more enduring problems among LIAB developers is that they tend to get “blinded by the beauty” of their technology.
Apr 22, 2025
-
Diagnostics World | Researchers at The University of Texas at El Paso (UTEP) are developing a point-of-care device for diagnosing colorectal cancer which, like blood glucose devices, uses electrochemical sensors. The microchip electrode features an immunosensor that detects disease biomarkers in a drop of blood, opening the possibility of an accessible, inexpensive test for the nation’s second leading cause of cancer-related deaths.
Apr 17, 2025
-
Diagnostics World | Magnetic flexible endoscopes (MFEs) have up to now had a few disadvantages limiting their use inside the human body for performing virtual biopsies, notably navigation-related difficulties related to their traditional cylindrical shape. These robot-assisted devices use magnetic forces to propel and maneuver through lumens like the colon, but rotation happens in only two directions that limits the scope's ability to effectively perform procedures.
Apr 16, 2025
-
Diagnostics World | The “bioenergetic capacity” of individuals, as marked by the level of certain cognition-associated molecules in the blood, could potentially be predictive of the risk of developing Alzheimer’s and other age-related diseases. A simulated clinical trial suggests that turning back the wheels on that biological clock could be just as effective at slowing cognitive decline as the latest drug to be approved for that purpose by the U.S. Food and Drug Administration.
Apr 15, 2025
-
Diagnostics World | Researchers worldwide are looking to revamp traditional approaches to medical imaging and develop alternative solutions that could improve visualization, speed, and accuracy in diagnostic settings. At the University of Arkansas, for example, one group is developing an AI tool designed to help radiologists and doctors analyze chest X-rays and computed tomography (CT) scans, with an emphasis on understanding how the AI assistant arrives at its conclusions.
Apr 10, 2025
-
Diagnostics World | The impact of the throat microbiome on the health of older individuals has gone unappreciated, especially among individuals being cared for in long-term care facilities. One big reason is that they are largely isolated and often forgotten by the public, even as these facilities have become home to a greater proportion of the overall population.
Apr 8, 2025
-
Diagnostics World | Atrial Fibrillation (AFib) is a fast-growing public health crisis—three times more common than once thought. Today, at least 10.55 million US adults have AFib, far exceeding the 3.3 million cases researchers predicted for the year 2020 in 1996. And this crisis is only growing.
Apr 4, 2025